GLP1R and Glucose intolerance: Administration of the GLP-1R agonist liraglutide before the onset of WS symptoms offers great protection against disease progression by postponing the development of glucose intolerance (as opposed to late intervention) [18] and protecting against vision loss [19,20] current paper in an animal model of WS.